Evaluation of omadacycline against intracellular Mycobacterium abscessus in an infection model in human macrophages

BACKGROUND: Omadacycline is an aminomethylcycline antibiotic in the tetracycline class that was approved by the US FDA in 2018 for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. It is available in both IV and oral formulations. Omadacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahanbakhsh, S, Howland, J, Ndayishimiye Uwineza, M O, Thwaites, M T, Pillar, C M, Serio, A W, Anastasiou, D M, Hufnagel, D A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502775/
https://www.ncbi.nlm.nih.gov/pubmed/37720564
http://dx.doi.org/10.1093/jacamr/dlad104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502775/
https://www.ncbi.nlm.nih.gov/pubmed/37720564
http://dx.doi.org/10.1093/jacamr/dlad104

Ejemplares similares